» Articles » PMID: 37572129

Issue Analysis: Key Characteristics Approach for Identifying Endocrine Disruptors

Overview
Journal Arch Toxicol
Specialty Toxicology
Date 2023 Aug 12
PMID 37572129
Authors
Affiliations
Soon will be listed here.
Abstract

For more than a decade, weight of evidence (WoE) evaluations have been the standard method for determining whether a chemical meets the definition of an endocrine disrupting chemical (EDC). WoE methods consider all data pertinent to satisfying the EDC definition and evaluating those data with respect to relevance, reliability, strength, and coherence with established endocrine physiology and pharmacology. A new approach for identifying EDC hazards has been proposed that organizes and evaluates data according to ten so-called "Key Characteristics (KCs) of EDCs". The approach claims to address the lack of a widely accepted, systematic approach for identifying EDC hazards, but completely ignores the WoE literature for EDCs. In contrast to WoE methods, the KC approach fails to apply the consensus definition of EDC and is not amenable to empirical testing or validation, is fungible and ensures inconsistent and unreliable results, ignores principles of hormone action and characteristics of dose-response in endocrine pharmacology and toxicology, lacks a means of distinguishing endocrine-mediated from non-endocrine mediated mechanisms, lacks a means to reach a negative conclusion about a chemical's EDC properties or to distinguish EDCs from non-EDCs, and provides no means for developing a valid consensus among experts nor provides a means of resolving conflicting interpretations of data. Instead of shortcuts like the KC approach, which are prone to bias, error, and arbitrary conclusions, identifying EDCs should rely on WoE evaluations that supply the critical components and scientific rigor lacking in the proposed KCs for EDCs.

References
1.
Al-Zoughool M, Bird M, Rice J, Baan R, Billard M, Birkett N . Development of a database on key characteristics of human carcinogens. J Toxicol Environ Health B Crit Rev. 2019; 22(7-8):264-287. DOI: 10.1080/10937404.2019.1642593. View

2.
Arzuaga X, Smith M, Gibbons C, Skakkebaek N, Yost E, Beverly B . Proposed Key Characteristics of Male Reproductive Toxicants as an Approach for Organizing and Evaluating Mechanistic Evidence in Human Health Hazard Assessments. Environ Health Perspect. 2019; 127(6):65001. PMC: 6792367. DOI: 10.1289/EHP5045. View

3.
Becker R, Dreier D, Manibusan M, Cox L, Simon T, Bus J . How well can carcinogenicity be predicted by high throughput "characteristics of carcinogens" mechanistic data?. Regul Toxicol Pharmacol. 2017; 90:185-196. DOI: 10.1016/j.yrtph.2017.08.021. View

4.
Borgert C, Mihaich E, Ortego L, Bentley K, Holmes C, Levine S . Hypothesis-driven weight of evidence framework for evaluating data within the US EPA's Endocrine Disruptor Screening Program. Regul Toxicol Pharmacol. 2011; 61(2):185-91. DOI: 10.1016/j.yrtph.2011.07.007. View

5.
Borgert C, Matthews J, Baker S . Human-relevant potency threshold (HRPT) for ERα agonism. Arch Toxicol. 2018; 92(5):1685-1702. PMC: 5962616. DOI: 10.1007/s00204-018-2186-z. View